Wall Street analysts expect that Express Scripts Holding Company (NASDAQ:ESRX) will report sales of $25.67 billion for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Express Scripts Holding’s earnings. The highest sales estimate is $26.07 billion and the lowest is $25.34 billion. Express Scripts Holding posted sales of $25.41 billion during the same quarter last year, which would indicate a positive year over year growth rate of 1%. The firm is expected to issue its next earnings results after the market closes on Tuesday, October 24th.

On average, analysts expect that Express Scripts Holding will report full year sales of $25.67 billion for the current fiscal year, with estimates ranging from $99.99 billion to $102.31 billion. For the next fiscal year, analysts expect that the business will report sales of $103.44 billion per share, with estimates ranging from $100.40 billion to $106.25 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Express Scripts Holding.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. Express Scripts Holding’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.57 EPS.

Several research analysts have issued reports on ESRX shares. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Jefferies Group LLC set a $72.00 price target on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Needham & Company LLC started coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating on the stock. Cowen and Company restated an “outperform” rating and issued a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. Finally, BidaskClub lowered shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Four analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $70.24.

In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction on Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the sale, the director now owns 11,500 shares of the company’s stock, valued at approximately $735,195. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,641 shares of company stock valued at $357,317. 0.68% of the stock is owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in ESRX. Waldron LP acquired a new stake in shares of Express Scripts Holding in the 1st quarter valued at $206,000. Brookstone Capital Management lifted its stake in shares of Express Scripts Holding by 7.7% in the 1st quarter. Brookstone Capital Management now owns 5,204 shares of the company’s stock valued at $343,000 after purchasing an additional 371 shares during the last quarter. Grace & White Inc. NY lifted its stake in shares of Express Scripts Holding by 3.8% in the 1st quarter. Grace & White Inc. NY now owns 4,741 shares of the company’s stock valued at $312,000 after purchasing an additional 172 shares during the last quarter. Advisory Services Network LLC acquired a new stake in shares of Express Scripts Holding in the 1st quarter valued at $646,000. Finally, Bowling Portfolio Management LLC acquired a new stake in shares of Express Scripts Holding in the 1st quarter valued at $3,953,000. 88.71% of the stock is owned by institutional investors and hedge funds.

Shares of Express Scripts Holding (NASDAQ ESRX) opened at 62.34 on Friday. Express Scripts Holding has a one year low of $57.80 and a one year high of $77.50. The firm’s 50-day moving average price is $61.88 and its 200-day moving average price is $63.29. The firm has a market cap of $36.00 billion, a PE ratio of 10.82 and a beta of 0.88.

COPYRIGHT VIOLATION WARNING: “$25.67 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/09/15/25-67-billion-in-sales-expected-for-express-scripts-holding-company-esrx-this-quarter.html.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Get a free copy of the Zacks research report on Express Scripts Holding (ESRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.